SRBT OTC
Shanrong Biotechnology Corp.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -99.9%
1Y: -100.0%
3Y: -100.0%
5Y: -99.8%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$24K
-43.4% ▼
Net Income
-$24K
-43.4% ▼
EPS (Diluted)
$-0.05
-43.5% ▼
EBITDA
-$24K
-43.4% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2017 | FY2018 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $32K | $223K | $79K | $16K | $24K |
| Operating Expenses | $32K | $447K | $79K | $16K | $24K |
| Operating Income | -$32K | -$447K | -$79K | -$16K | -$24K |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$32K | -$223K | -$79K | -$16K | -$24K |
| Tax Expense | $0 | -$223K | $0 | $0 | $0 |
| Net Income | -$32K | $0 | -$79K | -$16K | -$24K |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.07 | $0.00 | $-0.16 | $-0.03 | $-0.05 |
| EBITDA | -$32K | -$447K | -$79K | -$16K | -$24K |
| Shares Outstanding | 484853 | 484853 | 484853 | 484853 | 484853 |